S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.38 (-1.47%)
BABA   72.14 (-0.26%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+10.74%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.51%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.38 (-1.47%)
BABA   72.14 (-0.26%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+10.74%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.51%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.38 (-1.47%)
BABA   72.14 (-0.26%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+10.74%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.51%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.38 (-1.47%)
BABA   72.14 (-0.26%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+10.74%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.51%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)

United Therapeutics (UTHR) News Today

$241.65
-0.42 (-0.17%)
(As of 04:00 PM ET)
Compare
Today's Range
$240.09
▼
$244.41
50-Day Range
$219.23
▼
$242.07
52-Week Range
$204.44
▼
$283.09
Volume
210,123 shs
Average Volume
389,530 shs
Market Capitalization
$11.36 billion
P/E Ratio
13.31
Dividend Yield
N/A
Price Target
$296.29
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
marketbeat.com logoUnited Therapeutics (NASDAQ:UTHR) Receives New Coverage from Analysts at Wells Fargo & Company
marketbeat.com - December 8 at 8:34 AM
marketbeat.com logoUnited Therapeutics Co. (NASDAQ:UTHR) EVP Sells $1,433,340.00 in Stock
marketbeat.com - December 7 at 6:35 PM
tmcnet.com logoUnited Therapeutics Named by Newsweek as One of America's Most Responsible Companies 2024
tmcnet.com - December 7 at 7:58 AM
finance.yahoo.com logoUnited Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024
finance.yahoo.com - December 7 at 7:58 AM
marketbeat.com logoUniSuper Management Pty Ltd Invests $15.45 Million in United Therapeutics Co. (NASDAQ:UTHR)
marketbeat.com - December 6 at 9:40 AM
marketbeat.com logoUnited Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by BlackRock Inc.
marketbeat.com - December 3 at 7:58 AM
MarketBeat logoZacks Research Weighs in on United Therapeutics Co.'s Q1 2024 Earnings (NASDAQ:UTHR)
americanbankingnews.com - December 3 at 1:38 AM
finance.yahoo.com logoUnited Therapeutics (UTHR) Up 5.2% Since Last Earnings Report: Can It Continue?
finance.yahoo.com - December 1 at 5:10 PM
marketbeat.com logoEagle Health Investments LP Buys 39,600 Shares of United Therapeutics Co. (NASDAQ:UTHR)
marketbeat.com - December 1 at 11:21 AM
marketbeat.com logoEquities Analysts Issue Forecasts for United Therapeutics Co.'s Q1 2024 Earnings (NASDAQ:UTHR)
marketbeat.com - December 1 at 7:28 AM
MarketBeat logoHead-To-Head Survey: United Therapeutics (NASDAQ:UTHR) & GH Research (NASDAQ:GHRS)
americanbankingnews.com - December 1 at 1:56 AM
bizjournals.com logoUnited Therapeutics extends licensing deal with Eli Lilly even as generic competition intensifies
bizjournals.com - November 30 at 4:08 PM
benzinga.com logoUnited Therapeutics Stock (NASDAQ:UTHR) Dividends: History, Yield and Dates
benzinga.com - November 28 at 4:12 PM
finance.yahoo.com logoWhy United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term
finance.yahoo.com - November 24 at 12:33 PM
finance.yahoo.com logoInsider Sell Alert: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United ...
finance.yahoo.com - November 18 at 9:43 AM
finance.yahoo.com logoJim Simons Stock Portfolio: 12 Biggest Healthcare Stocks
finance.yahoo.com - November 13 at 11:03 PM
finance.yahoo.com logo3d Systems (DDD) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 8 at 3:23 PM
hk.finance.yahoo.com logoUnited Therapeutics Corp (UTHR) Reports 18% YoY Revenue Growth in Q3 2023
hk.finance.yahoo.com - November 3 at 7:03 PM
finance.yahoo.com logoUnited Therapeutics Corporation (NASDAQ:UTHR) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 2 at 2:13 PM
markets.businessinsider.com logoStrong Demand for Tyvaso DPI and Potential Market Growth Underpin Buy Rating for UTHR
markets.businessinsider.com - November 2 at 9:12 AM
finance.yahoo.com logoQ3 2023 United Therapeutics Corp Earnings Call
finance.yahoo.com - November 2 at 12:12 AM
bizjournals.com logoSilver Spring’s United Therapeutics betting big on organ manufacturing despite death of pig heart recipient
bizjournals.com - November 1 at 7:12 PM
seekingalpha.com logoUnited Therapeutics Corporation 2023 Q3 - Results - Earnings Call Presentation
seekingalpha.com - November 1 at 5:36 PM
finance.yahoo.com logoUnited Therapeutics (UTHR) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
finance.yahoo.com - November 1 at 2:11 PM
benzinga.com logoHealth Care Company United Therapeutics Announces Acquisition of Miromatrix Medical
benzinga.com - November 1 at 9:11 AM
finance.yahoo.com logoUnited Therapeutics Corporation Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 1 at 9:11 AM
bizjournals.com logoSilver Spring's United Therapeutics reaches $91M deal to buy Miromatrix Medical
bizjournals.com - October 31 at 7:20 AM
finance.yahoo.com logoUnited Therapeutics Corporation to Present at the UBS Biopharma Conference 2023
finance.yahoo.com - October 31 at 7:20 AM
finance.yahoo.com logoUnited Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis
finance.yahoo.com - October 31 at 7:20 AM
bizjournals.com logoMiromatrix Medical acquired by United Therapeutics two years after IPO
bizjournals.com - October 30 at 10:15 AM
businesswire.com logoUnited Therapeutics to Acquire Miromatrix Medical
businesswire.com - October 30 at 6:01 AM
markets.businessinsider.com logoAnalysts Conflicted on These Healthcare Names: Quest Diagnostics (DGX) and United Therapeutics (UTHR)
markets.businessinsider.com - October 25 at 9:04 PM
finance.yahoo.com logoUnited Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023
finance.yahoo.com - October 25 at 8:54 AM
msn.com logoUnited Therapeutics Shifts Focus To Tyvaso DPI Amidst Generic Threat
msn.com - October 23 at 8:53 AM
seekingalpha.com logoUnited Therapeutics: Both Fundamental And Technical Analyses Justify A Buy Decision
seekingalpha.com - October 22 at 12:25 PM
marketbeat.com logoUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Robeco Institutional Asset Management B.V.
marketbeat.com - October 10 at 5:01 AM
marketbeat.com logoUnited Therapeutics Co. (NASDAQ:UTHR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
marketbeat.com - October 7 at 2:52 AM
marketbeat.com logoAssenagon Asset Management S.A. Sells 177,385 Shares of United Therapeutics Co. (NASDAQ:UTHR)
marketbeat.com - October 6 at 12:00 PM
marketbeat.com logoUnited Therapeutics (NASDAQ:UTHR) Coverage Initiated by Analysts at StockNews.com
marketbeat.com - October 6 at 1:41 AM
marketbeat.com logoTeacher Retirement System of Texas Has $2.66 Million Holdings in United Therapeutics Co. (NASDAQ:UTHR)
marketbeat.com - October 4 at 5:03 AM
marketbeat.com logoAsahi Life Asset Management CO. LTD. Invests $285,000 in United Therapeutics Co. (NASDAQ:UTHR)
marketbeat.com - October 3 at 7:17 AM
finance.yahoo.com logoUnited Therapeutics Corporation's (NASDAQ:UTHR) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
finance.yahoo.com - October 1 at 12:16 PM
marketbeat.com logoAllspring Global Investments Holdings LLC Has $38.17 Million Holdings in United Therapeutics Co. (NASDAQ:UTHR)
marketbeat.com - October 1 at 4:56 AM
marketbeat.com logoRonald Blue Trust Inc. Has $40,000 Holdings in United Therapeutics Co. (NASDAQ:UTHR)
marketbeat.com - September 30 at 4:39 AM
marketbeat.com logoTFB Advisors LLC Buys 431 Shares of United Therapeutics Co. (NASDAQ:UTHR)
marketbeat.com - September 28 at 7:20 AM
marketbeat.com logoNew Mexico Educational Retirement Board Acquires 1,000 Shares of United Therapeutics Co. (NASDAQ:UTHR)
marketbeat.com - September 27 at 6:20 AM
marketbeat.com logoFirst Trust Direct Indexing L.P. Has $468,000 Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)
marketbeat.com - September 26 at 4:50 AM
uk.finance.yahoo.com logoUnited Therapeutics Corp (UTH.BE)
uk.finance.yahoo.com - September 25 at 2:19 PM
finance.yahoo.com logoUnited Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs
finance.yahoo.com - September 22 at 6:59 PM
marketbeat.com logoUnited Therapeutics Co. (NASDAQ:UTHR) EVP Sells $1,333,140.00 in Stock
marketbeat.com - September 22 at 5:32 PM
Get United Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter.



UTHR Media Mentions By Week

UTHR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

UTHR
News Sentiment
▼
1.14

0.52
▲
Average
Medical
News Sentiment

UTHR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

UTHR Articles
This Week
▼
12

4
▲
UTHR Articles
Average Week

Get United Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:UTHR) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -